QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 限定条件 发表日期：2020    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Beyond Blocking: Engineering RNAi-Mediated Targeted Immune Checkpoint Nanoblocker Enables T-Cell-lndependent Cancer Treatment 期刊论文 ACS NANO, 2020, 卷号: 14 作者:  Han, Xiaoyan;  Wang, Linlin;  Li, Ting;  Zhang, Jiahui;  Zhang, Dailiang 收藏  |  浏览/下载：54/0  |  提交时间：2021/03/15 immune checkpoint blockade  RNAi engineering  nanostructure  NSCLC  cancer immunotherapy   Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions 期刊论文 THORACIC CANCER, 2020 作者:  Chen, Kaiyan;  Pan, Guoqiang;  Cheng, Guoping;  Zhang, Fanrong;  Xu, Yanjun 收藏  |  浏览/下载：40/0  |  提交时间：2020/12/28 EGFR  HER2  immunotherapy  NSCLC  PD‐  L1   A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC 期刊论文 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8 作者:  Wang, Wenxiang;  Wu, Lin;  Zhang, Wei;  Lu, Shun;  Fang, Haohui 收藏  |  浏览/下载：38/0  |  提交时间：2021/03/15 Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Wang, Wenxian;  Huang, Zhangzhou;  Yu, Zongyang;  Zhuang, Wu;  Zheng, Weijun 收藏  |  浏览/下载：33/0  |  提交时间：2020/11/30 immune checkpoint inhibitor  non-small cell lung cancer  biomarker  chemotherapy  lung immune prognostic index   PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Wei, Qing;  Yuan, Xing;  Li, Jingjing;  Xu, Qi;  Ying, Jieer 收藏  |  浏览/下载：30/0  |  提交时间：2020/11/30 Programmed death 1 (PD-1)  gastric cancer (GC)  immune checkpoint inhibitors  immunotherapy  apatinib   Circular Bispecific Aptamer-Mediated Artificial Intercellular Recognition for Targeted T Cell Immunotherapy 期刊论文 ACS NANO, 2020, 卷号: 14 作者:  Yang, Yu;  Sun, Xiaoqi;  Xu, Jun;  Cui, Cheng;  Yazd, Hoda Safari 收藏  |  浏览/下载：41/0  |  提交时间：2020/10/26 recognition-then-activation  circular bispecific aptamer  cb-aptamer  adoptive T cell immunotherapy  T cell immunotherapy  on shelf   Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2020, 卷号: 9 作者:  Zhou, Qinfei;  Zhao, Jiazheng;  Wang, Jie;  Bao, Guanai;  Gong, Li-Yan 收藏  |  浏览/下载：25/0  |  提交时间：2020/11/26 Small-cell lung cancer (SCLC)  immunotherapy  durvalumab  third-line treatment  case report   Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors 期刊论文 ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020 作者:  Zhang, Da;  Zheng, Youshi;  Lin, Ziguo;  Liu, Xiaolong;  Li, Juan 收藏  |  浏览/下载：16/0  |  提交时间：2020/11/26 aptamers  immunology  natural killer cells  PD1  PDL1 checkpoint blockade  solid tumors   Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun 收藏  |  浏览/下载：21/0  |  提交时间：2020/10/26 tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)   PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文 LUNG CANCER, 2020, 卷号: 142 作者:  Chen, Kaiyan;  Cheng, Guoping;  Zhang, Fanrong;  Zhu, Guanxia;  Xu, Yanjun 收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26 Uncommon EGFR  Non-small cell lung cancer  PD-L1  T cell  Immunotherapy